SlideServe
Télécharger Obtenir Pro
Menu
Accueil Pro
Préférences
ApparenceLight Aide et commentaires
© SlideServe · v2026

A global strategy to eliminating blinding trachoma

neva avatar
neva
19 diapositives · 332 Views · Nov 11, 2012

Trachoma is a leading cause of preventable blindness worldwide, primarily affecting impoverished communities. This bacterial infection causes chronic eye inflammation, leading to vision loss and blindness, especially among children. The WHO aims for the prevalence of blinding trachoma to fall below 5% in children. The "2020 INSight" strategic plan focuses on urgent actions through the SAFE strategy (Surgery, Antibiotics, Facial cleanliness, Environmental improvements). With a commitment to strong partnerships, we can combat this disease and enhance the quality of life for millions.

#trachoma #preventable blindness #safe strategy #global health #eye infection #vision loss #ntds #community health
A global strategy to eliminating blinding trachoma - slide 1
01 / 19A global strategy to eliminating blinding trachoma
1 / 17

Télécharger la présentation

A global strategy to eliminating blinding trachoma
Une image / un lien ci-dessous est fourni (tel quel) pour télécharger la présentation

Politique de téléchargement : le contenu du site vous est fourni TEL QUEL pour votre information et votre usage personnel ; il ne peut être vendu, concédé sous licence ni partagé sur d’autres sites sans l’accord de son auteur.Le contenu vous est fourni TEL QUEL, pour votre information et votre usage personnel uniquement. Téléchargez la présentation en cliquant sur ce lien. Lors du téléchargement, si vous ne parvenez pas à télécharger une présentation, l’éditeur a peut-être supprimé le fichier de son serveur.Pendant le téléchargement, si vous ne parvenez pas à obtenir une présentation, le fichier a peut-être été supprimé par l’éditeur.

F I N

Plus de contenu associé

Transcription de la présentation

  1. A global strategy to eliminate blinding trachoma

  2. We Can Eliminate Trachoma

  3. What is trachoma? • Trachoma is the leading cause of preventable blindness worldwide • Mainly affects the poorest areas of the world • Bacterial infection that leads to chronic eye inflammation • Re-infection, scarring and trauma to cornea eventually lead to blindness • Typically, children are infected at an early age and develop vision loss and blindness later in life trachomacoalition.org 2020 INSight

  4. What is trachoma? • Every 4 minutes, 1 person experiences severe sight loss; every hour, 4 people become blind • WHO defines blinding trachoma elimination as: • TF prevalence <5% in 1-9 year old children • TT prevalence <1 per 1000 in total population trachomacoalition.org 2020 INSight

  5. What is “2020 INSight”?

  6. What is “2020 INSight”? • Outline of this strategic plan is structured around four questions: • Where are we? • Where do we want to go? • How do we get there? • What is the cost of eliminating trachoma? trachomacoalition.org 2020 INSight

  7. Where are we?

  8. Where are we? • 110 million people need treatment in confirmed endemic areas • 210 million more live in areas where trachoma is suspected • Trachoma is suspected to be endemic in 59 countries • 24% of these countries carry 80% of the burden • Using WHO-endorsed SAFE strategy to eliminate trachoma • Surgery, Antibiotics, Facial cleanliness, Environmental improvements • Progress is significant- 9 countries have achieved their UIG • Strong spirit of collaboration among trachoma control programs trachomacoalition.org 2020 INSight

  9. Where are we?SAFE Strategy trachomacoalition.org 2020 INSight

  10. Where are we? TrachomaCoalition.org trachomacoalition.org 2020 INSight

  11. Where are we? TrachomaAtlas.org trachomacoalition.org 2020 INSight

  12. Where do we want to go?

  13. Where do we want to go? Model for surgery scale-up Model for antibiotics scale-up trachomacoalition.org 2020 INSight

  14. How do we get there?

  15. How do we get there? Guiding principles of elimination plan: • Urgent need for action • Aim for fastest possible timeline in each district and focus on high-burden countries • Accountable ownership • Countries lead their own elimination process • Integration of trachoma-focused efforts • With other NTDs, Vision 2020, F & E initiatives • Efficient, coordinated partnerships • Tailored local interventions trachomacoalition.org 2020 INSight

  16. How do we get there? Milestones to 2020 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 Country strategy in place in sync with NTD plans -- high burden countries 50% 100% Assessment complete -- high burden countries 50% 75% 100% Country strategy in place in sync with NTD plans -- other 50% 100% Planning and Funding Assessment complete -- other countries 50% 75% 100% % of countries with impact surveys done 50% 100% % of countries with post-endemic surveillance plan 35% 50% 100% % of surgery backlog addressed 50% 75% 100% % of population in mapped districts with A-started 50% 100% Interventions 50% 100% % of mapped districts with F interventions % of mapped districts with E interventions 50% 100% % of countries having reached UIGs in all districts 35% 50% 100% Certification % of countries having reached certification 35% 50% trachomacoalition.org 2020 INSight

  17. What is the cost of elimination?

  18. What is the cost of elimination? • Economic burden of trachoma  $3-6 billion in annual productivity loss • Estimated cost of elimination  $430 million for confirmed burden trachomacoalition.org 2020 INSight

  19. The challenge for the coming years is large, but with the incredible momentum created through our partnerships, together, we can reach our shared goals. Thank You! www.trachoma.org www.trachomaatlas.org www.trachomacoalition.org trachomacoalition.org 2020 INSight